Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients-Reference-Cited by-同舟云学术

Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients

Published:2018-06-01 Issue:9 Volume:32 Page:1095-1105
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Medrano Luz M.,Garcia-Broncano Pilar,Berenguer Juan,González-García Juan,Jiménez-Sousa Ma Ángeles,Guardiola Josep M.,Crespo Manuel,Quereda Carmen,Sanz José,Canorea Isabel,Carrero Ana,Hontañón Victor,Muñoz-Fernández Ma Ángeles,Resino Salvador

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference71 articles.

1. Viral hepatitis in HIV infection;Koziel;N Engl J Med,2007

2. Changes in causes of death among adults infected by HIV between 2000 and 2005: the ‘Mortalite 2000 and 2005’ surveys (ANRS EN19 and Mortavic);Lewden;J Acquir Immune Defic Syndr,2008

3. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis;Graham;Clin Infect Dis,2001

4. Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study;Lo Re;Ann Intern Med,2014

5. Immunologic biomarkers, morbidity, and mortality in treated HIV infection;Hunt;J Infect Dis,2016

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the expression of fibrosis-related genes as non-invasive diagnostic biomarkers for cirrhotic HCV-infected patients;Cytokine;2024-10

2. Sustained Long-Term Decline in Anti-HCV Neutralizing Antibodies in HIV/HCV-Coinfected Patients Five Years after HCV Therapy: A Retrospective Study;Pharmaceuticals;2024-08-30

3. Association of serum lipid profile with liver fibrosis in HCV‑coinfected HIV patients on suppressive anti‑retroviral therapy;Biomedical Reports;2024-08-13

4. The Era of DAAs: Assessing the Patients’ Characteristics, Clinical Impact, and Emergence of Comorbidities in HIV/HCV-Coinfected versus HIV-Infected Individuals;Journal of Clinical Medicine;2024-07-04

5. Important Risk Factors of Liver Cirrhosis in HIV and Hepatitis C Coinfected Patients: A Systematic Review;The Open AIDS Journal;2024-02-29